| Eric D Schubert, MD | |
|
2525 Desales Avenue, Pathology Laboratory, Chattanooga, TN 37404 | |
| (423) 495-8703 | |
| (423) 495-6175 |
| Full Name | Eric D Schubert |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 2525 Desales Avenue, Chattanooga, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124080304 | NPI | - | NPPES |
| 3819593 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | MD00030034 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Eric D Schubert, MD Po Box 3637, Attn Judy Nowlin, Chattanooga, TN 37404 Ph: (423) 629-7688 | Eric D Schubert, MD 2525 Desales Avenue, Pathology Laboratory, Chattanooga, TN 37404 Ph: (423) 495-8703 |
News Archive
Scientists at The Feinstein Institute for Medical Research have discovered a new, personalized approach to diagnosing low back pain. The findings from a clinical study show that serum levels of the proinflammatory cytokine interleukin-6 (IL-6) vary in individuals with lumbar intervertebral disc disease and that biochemical profiling of circulating cytokines may assist in refining personalized diagnoses of disc diseases.
The Deutsche Forschungsgemeinschaft has approved the establishment of twelve new Collaborative Research Centres beginning 1 July 2010. This was decided by the responsible Grants Committee at its spring meeting in Bonn. The new CRCs will initially be funded for four years with a total of 112 million euros (including a 20% programme allowance for indirect project costs).
Anesiva, Inc. announced today that on December 2, 2009, Anesiva received a letter from The NASDAQ Stock Market ("Nasdaq") stating that Anesiva was required to maintain a minimum Market Value of Publicly Held Shares (MVPHS) of $5,000,000 during the last 30 consecutive business days and that therefore
Yesterday, the European Patent Office (EPO) revoked previously granted claims of Cellectis' European Patent No. EP 1485475 during an oral hearing in an opposition proceeding initiated by Precision BioSciences. As a result of the opposition, Cellectis' previously granted claims to single-chain meganucleases, including those derived from I-CreI, were revoked in their entirety. Claims to hybrid meganucleases were cancelled or severely restricted.
› Verified 2 days ago
Abubaker A Elshaikh, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 423-778-7000 | |
Dr. Summer Lee Bohman, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 615-695-4977 | |
Imelda S Bulatao, MD Pathology Medicare: Medicare Enrolled Practice Location: 2525 Desales Ave, Pathology Laboratory, Chattanooga, TN 37404 Phone: 423-495-8703 Fax: 423-495-6175 | |
John T Bickel, MD Pathology Medicare: Medicare Enrolled Practice Location: 2525 Desales Avenue, Pathology Laboratory, Chattanooga, TN 37404 Phone: 423-495-8703 Fax: 423-495-6175 | |
Gary R Lanham, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 2333 Mccallie Ave, Chattanooga, TN 37404 Phone: 423-493-1550 | |
Ronald W Oxenhandler, MD Pathology Medicare: Medicare Enrolled Practice Location: 2525 Desales Ave, Pathology Laboratory, Chattanooga, TN 37404 Phone: 423-495-8703 Fax: 423-495-6175 |